Associated Papers
A comprehensive benchmark for multiple highly efficient base editors with broad targeting scope.
Wang X et al.
Biorxiv : the Preprint Server for Biology, 2025
Normal meninges harbor oncogenic somatic mutations in meningioma-driver genes.
Boetto J et al.
Acta Neuropathologica, 2023
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
Youngblood MW et al.
Nature Communications, 2023
Uncovering the molecular landscape of meningiomas and the impact of perioperative steroids on patient survival.
Furtak J et al.
Acta Neurochirurgica, 2023
Pleiotropic role of TRAF7 in skull-base meningiomas and congenital heart disease.
Mishra-Gorur K et al.
Proceedings of the National Academy of Sciences of the United States of America, 2023
Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS et al.
Brain Pathology (zurich, Switzerland), 2022
Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing.
Kim J et al.
Frontiers in Oncology, 2022
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
González-Tablas M et al.
Frontiers in Oncology, 2021
Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7.
Castilla-Vallmanya L et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020
Molecular characterization of localized pleural mesothelioma.
Hung YP et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2020
Whole exome sequencing of multiple meningiomas with varying histopathological presentation in one patient revealed distinctive somatic mutation burden and independent clonal origins.
Sheng HS et al.
Cancer Management and Research, 2019
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Clark VE et al.
Science (new York, N.y.), 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
Reuss DE et al.
Acta Neuropathologica, 2013